Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Describe your process for conducting internal audits and how you address findings.

Posted on August 10, 2023August 10, 2023 By digi

Auditee: Conducting internal audits is a critical aspect of maintaining a robust quality management system and ensuring compliance with FDA regulations. Here’s a description of our process for conducting internal audits and addressing findings:

Step 1: Audit Planning

  • Audit Schedule: An annual audit schedule is developed, outlining the areas, processes, and functions that will be audited throughout the year.
  • Audit Criteria: Audit criteria are established based on FDA regulations, industry standards, and our internal policies and procedures.
  • Audit Team: A team of trained internal auditors is selected to conduct the audits. Auditors are independent from the areas being audited.

Step 2: Audit Execution

  • Preparation: Auditors review
relevant documentation, procedures, and previous audit reports to familiarize themselves with the area being audited.
  • Audit Plan: An audit plan is developed, outlining the scope, objectives, and methods of the audit.
  • On-Site Audit: Auditors visit the audited area, conduct interviews with personnel, review records, and observe processes to assess compliance and identify potential gaps.
  • Step 3: Finding Identification

    • Evidence Collection: Auditors collect objective evidence to support findings, such as non-compliance with procedures, incomplete records, or deviations from standards.
    • Finding Classification: Findings are classified based on their severity and potential impact on product quality, patient safety, or regulatory compliance.

    Step 4: Audit Report and Findings

    • Audit Report: A comprehensive audit report is prepared, detailing the audit scope, methodology, findings, evidence, and observations.
    • Finding Documentation: Each finding is clearly documented, including the specific non-compliance, relevant regulations, and recommended corrective actions.

    Step 5: Corrective and Preventive Actions (CAPA)

    • Root Cause Analysis: For each finding, a thorough root cause analysis is conducted to determine the underlying reason for the non-compliance.
    • Corrective Actions: Corrective actions are defined and implemented to address the identified issues, prevent recurrence, and bring the processes into compliance.
    • Preventive Actions: In addition to addressing immediate issues, preventive actions are developed to mitigate potential risks and improve overall processes.

    Step 6: Follow-Up and Verification

    • Implementation Verification: Auditors verify that corrective and preventive actions have been implemented effectively and are addressing the identified issues.
    • Effectiveness Evaluation: The effectiveness of corrective and preventive actions is assessed to ensure sustained compliance and process improvement.

    Through this systematic process, we conduct internal audits to identify areas for improvement, ensure compliance with FDA regulations, and continuously enhance our quality management system. The focus on addressing findings through corrective and preventive actions helps us maintain product quality, regulatory compliance, and patient safety.

    US FDA Mock Audits Tags:Audit process, Batch Record Review and Approval in GMP, Benefits of GMP Implementation, Cleaning and Sanitation in GMP Facilities, Compliance documentation, Contamination Prevention, Corrective actions, Deviations and Non-Conformities in GMP, Documentation Requirements in GMP, Equipment Calibration and Maintenance in GMP, GMP, GMP Enforcement and Monitoring, GMP guidelines, GMP Regulations, Good Manufacturing Practices (GMP), Inspection procedures, Internal audits, Manufacturing validation, Non-Compliance Consequences, Personnel Training in GMP, Pharmaceutical Industry, Preventive measures, Process Validation in GMP, Product Quality and Safety, Product quality assurance, Quality Control (QC) in GMP Compliance, Quality control procedures, Quality management system, Raw Materials Control in GMP, Regulatory communication, Regulatory compliance, Risk assessment, Specifications and Acceptance Criteria under GMP, Stability Studies in GMP, Storage and Distribution of Pharmaceutical Products under GMP, US FDA Audit

    Post navigation

    Previous Post: How do you ensure that your products meet FDA requirements for identity, strength, quality, and purity?
    Next Post: Walk us through your process for handling and documenting employee training records.

    Menu

    • GMP Basics
      • Introduction to GMP
      • What is cGMP?
      • Key Principles of GMP
      • Benefits of GMP in Pharmaceuticals
      • GMP vs. GxP (Good Practices)
    • Regulatory Agencies & Guidelines
      • WHO GMP Guidelines
      • FDA GMP Guidelines
      • MHRA GMP Guidelines
      • SCHEDULE – M – Revised
      • TGA GMP Guidelines
      • Health Canada GMP Regulations
      • NMPA GMP Guidelines
      • PMDA GMP Guidelines
      • EMA GMP Guidelines
    • GMP Compliance & Audits
      • How to Achieve GMP Certification
      • GMP Auditing Process
      • Preparing for GMP Inspections
      • Common GMP Violations
      • Role of Quality Assurance
    • Quality Management Systems (QMS)
      • Building a Pharmaceutical QMS
      • Implementing QMS in Pharma Manufacturing
      • CAPA (Corrective and Preventive Actions) for GMP
      • QMS Software for Pharma
      • Importance of Documentation in QMS
      • Integrating GMP with QMS
    • Pharmaceutical Manufacturing
      • GMP in Drug Manufacturing
      • GMP for Biopharmaceuticals
      • GMP for Sterile Products
      • GMP for Packaging and Labeling
      • Equipment and Facility Requirements under GMP
      • Validation and Qualification Processes in GMP
    • GMP Best Practices
      • Total Quality Management (TQM) in GMP
      • Continuous Improvement in GMP
      • Preventing Cross-Contamination in Pharma
      • GMP in Supply Chain Management
      • Lean Manufacturing and GMP
      • Risk Management in GMP
    • Regulatory Compliance in Different Regions
      • GMP in North America (FDA, Health Canada)
      • GMP in Europe (EMA, MHRA)
      • GMP in Asia (PMDA, NMPA, KFDA)
      • GMP in Emerging Markets (GCC, Latin America, Africa)
      • GMP in India
    • GMP for Small & Medium Pharma Companies
      • Implementing GMP in Small Pharma Businesses
      • Challenges in GMP Compliance for SMEs
      • Cost-effective GMP Compliance Solutions for Small Pharma Companies
    • GMP in Clinical Trials
      • GMP Compliance for Clinical Trials
      • Role of GMP in Drug Development
      • GMP for Investigational Medicinal Products (IMPs)
    • International GMP Inspection Standards and Harmonization
      • Global GMP Inspection Frameworks
      • WHO Prequalification and Inspection Systems
      • US FDA GMP Inspection Programs
      • EMA and EU GMP Inspection Practices
      • PIC/S Role in Harmonized Inspections
      • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
    • GMP Blog
    Widget Image
    • Qualify HVAC Systems in Warehouses to Maintain GMP Storage Conditions

      Qualify HVAC Systems in Warehouses… Read more

    Mock Audits

    • US FDA Mock Audits

    US FDA Mock Audits

    • Can you provide an overview of your quality management system (QMS) and how it ensures compliance with FDA regulations?
    • How are employees trained on FDA regulations and guidelines relevant to their roles?
    • Can you demonstrate how your documentation practices ensure accuracy, traceability, and completeness?
    • How do you maintain and calibrate critical equipment used in your manufacturing process?
    • Show us your facility’s organization, cleanliness, and measures for preventing cross-contamination.
    • Explain your process for handling and documenting deviations from established procedures.
    • Provide examples of risk assessments you’ve conducted on your processes, products, and suppliers.
    • How do you manage and document changes to processes, equipment, or materials?
    • Walk us through your procedure for investigating and addressing customer complaints related to product quality.
    • Can you show us how you handle and document product recalls, if necessary?

    Copyright © 2025 Pharma GMP.

    Powered by PressBook WordPress theme